搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nipah virus Matrix protein (M) CSB-YP867446NDT
CSB-EP867446NDT
CSB-BP867446NDT
CSB-MP867446NDT
CSB-EP867446NDT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza C virus RNA-directed RNA polymerase catalytic subunit (PB1), partial CSB-YP867447IKI
CSB-EP867447IKI
CSB-BP867447IKI
CSB-MP867447IKI
CSB-EP867447IKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Banna virus RNA-directed RNA polymerase VP1, partial CSB-YP867448BFAY
CSB-EP867448BFAY
CSB-BP867448BFAY
CSB-MP867448BFAY
CSB-EP867448BFAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus RNA-directed RNA polymerase catalytic subunit (PB1), partial CSB-YP867449IIO
CSB-EP867449IIO
CSB-BP867449IIO
CSB-MP867449IIO
CSB-EP867449IIO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Potato mop-top virus Movement protein TGB1 CSB-YP867450PQX
CSB-EP867450PQX
CSB-BP867450PQX
CSB-MP867450PQX
CSB-EP867450PQX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine herpesvirus 4 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (Bo17), partial CSB-YP867451BGAF
CSB-EP867451BGAF
CSB-BP867451BGAF
CSB-MP867451BGAF
CSB-EP867451BGAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Avian infectious bronchitis virus Nucleoprotein (N) CSB-YP867452AKAQ
CSB-EP867452AKAQ
CSB-BP867452AKAQ
CSB-MP867452AKAQ
CSB-EP867452AKAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Putative ankyrin repeat protein FPV233 (FPV233), partial CSB-YP867453FEY
CSB-EP867453FEY
CSB-BP867453FEY
CSB-MP867453FEY
CSB-EP867453FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Putative ankyrin repeat protein FPV224 (FPV224) CSB-YP867454FEY
CSB-EP867454FEY
CSB-BP867454FEY
CSB-MP867454FEY
CSB-EP867454FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Probable serine/threonine-protein kinase FPV212 (FPV212) CSB-YP867455FEY
CSB-EP867455FEY
CSB-BP867455FEY
CSB-MP867455FEY
CSB-EP867455FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Viral replication protein A28-like (FPV192), partial CSB-YP867456FEY
CSB-EP867456FEY
CSB-BP867456FEY
CSB-MP867456FEY
CSB-EP867456FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Virion membrane protein A16 homolog (FPV181), partial CSB-YP867457FEY1
CSB-EP867457FEY1
CSB-BP867457FEY1
CSB-MP867457FEY1
CSB-EP867457FEY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Viral late gene transcription factor 3 (VLTF3) CSB-YP867458FEY
CSB-EP867458FEY
CSB-BP867458FEY
CSB-MP867458FEY
CSB-EP867458FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Probable dual specificity protein phosphatase H1 homolog (FPV138) CSB-YP867459FEY
CSB-EP867459FEY
CSB-BP867459FEY
CSB-MP867459FEY
CSB-EP867459FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Poly (A) polymerase catalytic subunit (PAPL) CSB-YP867460FEY
CSB-EP867460FEY
CSB-BP867460FEY
CSB-MP867460FEY
CSB-EP867460FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus 27 kDa core protein (FPV069, fp9.069) CSB-YP867461FEY
CSB-EP867461FEY
CSB-BP867461FEY
CSB-MP867461FEY
CSB-EP867461FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Putative ankyrin repeat protein FPV023 (FPV023) CSB-YP867462FEY
CSB-EP867462FEY
CSB-BP867462FEY
CSB-MP867462FEY
CSB-EP867462FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Uncharacterized serpin-like protein FPV010 (FPV010) CSB-YP867463FEY
CSB-EP867463FEY
CSB-BP867463FEY
CSB-MP867463FEY
CSB-EP867463FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vaccinia virus DNA-directed RNA polymerase 133 kDa polypeptide (RPO132), partial CSB-YP867464VAH
CSB-EP867464VAH
CSB-BP867464VAH
CSB-MP867464VAH
CSB-EP867464VAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vaccinia virus Myristoylated protein G9 (TG10R), partial CSB-YP867465VAH1
CSB-EP867465VAH1
CSB-BP867465VAH1
CSB-MP867465VAH1
CSB-EP867465VAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>